HIVClinicalForum
Meeting category
Date(s)
27 Oct 2018
Location
Glasgow, United Kingdom
Organizer

European HIV Clinical Forum 2018

Related Enduring Materials

Enduring Materials
Session 1: Integrase Inhibitors: an overview -
Clinical Overview - Integrase Inhibitors - What's New?
Margaret Johnson, MD, FRCP
Royal Free London NHS Foundation Trust, United Kingdom
Resistance to Integrase Inhibitors - What Clinicians Need to Know
Roger Paredes, MD, PhD
Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain
Session 2: Changing paradigm: Is reducing drug regimen an option? -
Reduced drug regimens - What are the Data?
José Arribas, MD
La Paz Hospital, Spain
Switch strategies
Pedro Cahn, MD, PhD
Fundación Huésped Buenos Aires, Argentina
Session 3: Real-life data presentations -
Integrase Inhibitors in special patient populations
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Abstract Presentation
Longer duration of virological suppression and a fully active companion drug ensure a high rate of virological control in HIV-1 infected patients switching to a dual therapy containing integrase inhibitors
Daniele Armenia - University of Rome “Tor Vergata”. Rome, Italy
Session 4: Novel Approaches -
Long acting ARV for treatment and prevention - clinical considerations
Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom
Novel delivery Systems - What's in the pipeline?
Courtney Fletcher
Courtney Fletcher, PharmD
University of Nebraska, Omaha (NE), USA
Overview
Welcome

We would like to thank you all for joining us at the European HIV Clinical Forum: Integrase Inhibitors 2018! Your excellent questions contributed to the great discussions and ultimate success of this meeting. We would also like to thank our speakers for giving their amazing lectures!

Presentation materials have been posted here, provided that the speaker's permission was granted. 

​On behalf of the European HIV Clinical Forum Program Chairs, we would like to thank ViiV Healthcare for their unrestricted educational grant and Gilead Sciences for their Gold-level sponsorship. We would also like to thank our endorsers for their invaluable support of the meeting.

Background

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.

Local Chair
Support
Language